Vestcor Inc Has $1.99 Million Stake in Tenet Healthcare Corporation $THC

Vestcor Inc cut its position in Tenet Healthcare Corporation (NYSE:THC) by 28.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,996 shares of the company’s stock after selling 3,990 shares during the quarter. Vestcor Inc’s holdings in Tenet Healthcare were worth $1,986,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of THC. Wedmont Private Capital lifted its position in shares of Tenet Healthcare by 2.5% in the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after purchasing an additional 50 shares during the period. Baron Wealth Management LLC increased its position in shares of Tenet Healthcare by 4.8% during the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after buying an additional 52 shares during the period. Sagespring Wealth Partners LLC lifted its holdings in Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after buying an additional 55 shares during the period. Crestwood Advisors Group LLC boosted its position in Tenet Healthcare by 2.5% during the third quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after acquiring an additional 64 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in Tenet Healthcare by 9.0% during the 4th quarter. Signaturefd LLC now owns 798 shares of the company’s stock worth $159,000 after acquiring an additional 66 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Trading Up 0.1%

NYSE:THC opened at $162.20 on Monday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The company has a market cap of $13.97 billion, a PE ratio of 8.43, a PEG ratio of 1.33 and a beta of 1.28. The firm has a 50-day moving average of $186.17 and a 200-day moving average of $200.80.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter in the previous year, the business earned $4.36 EPS. The company’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts expect that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Barclays cut their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Stephens dropped their price target on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Truist Financial raised their price objective on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Jefferies Financial Group boosted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Finally, Royal Bank Of Canada cut their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $244.16.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director directly owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 15,138 shares of company stock valued at $3,065,789. 0.97% of the stock is owned by insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.